Andrew Rappaport - Net Worth and Insider Trading

Over the past 18 months, Andrew Rappaport made no insider transaction in Splunk Inc (SPLK). Other recent insider transactions involving Splunk Inc (SPLK) include a net sale of 23,013 shares made by Scott Morgan , a net sale of 23,000 shares made by Christian Smith , and a net sale of 6,150 shares made by Elisa Steele .

In summary, during the past 3 months, insiders sold 0 shares of Splunk Inc (SPLK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 71,363 shares of Splunk Inc (SPLK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 71,363 shares.

Splunk Inc (SPLK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Andrew Rappaport made no insider transaction in Seagate Technology Holdings PLC (STX). Other recent insider transactions involving Seagate Technology Holdings PLC (STX) include a net sale of 173,103 shares made by Gianluca Romano , a net sale of 30,004 shares made by John Christopher Morris , and a net sale of 53,562 shares made by Ban Seng Teh .

In summary, during the past 3 months, insiders sold 89,137 shares of Seagate Technology Holdings PLC (STX) in total and bought 0 shares, with a net sale of 89,137 shares. During the past 18 months, 771,646 shares of Seagate Technology Holdings PLC (STX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 771,646 shares.

Seagate Technology Holdings PLC (STX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Andrew Rappaport made no insider transaction in Olema Pharmaceuticals inc (OLMA). Other recent insider transactions involving Olema Pharmaceuticals inc (OLMA) include a net sale of 338,181 shares made by Cyrus Harmon , a net sale of 44,370 shares made by David C. Myles , and a net sale of 2,300,000 shares made by Paradigm Biocapital Advisors Lp .

In summary, during the past 3 months, insiders sold 2,430,000 shares of Olema Pharmaceuticals inc (OLMA) in total and bought 0 shares, with a net sale of 2,430,000 shares. During the past 18 months, 4,048,074 shares of Olema Pharmaceuticals inc (OLMA) were sold and 2,255,932 shares were bought by its insiders, resulting in a net sale of 1,792,142 shares.

Olema Pharmaceuticals inc (OLMA)'s detailed insider trading history can be found in Insider Trading Tracker table.